Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis

A G Richter1, R A Stockley, L Harper

  • 1Lung Investigation Unit, 1st floor Nuffield House, Birmingham, UK. d.thickett@bham.ac.uk

Thorax
|April 11, 2009
PubMed
Abstract

Insights

Wegener granulomatosis (WG) patients show increased lower airway pathogens, particularly Staphylococcus aureus, in bronchoalveolar lavage fluid (BALF). WG BALF supports S. aureus growth, suggesting targeted antibiotic therapy.

Area of Science:

  • Pulmonology
  • Microbiology
  • Immunology

Background:

  • Wegener granulomatosis (WG) is linked to Staphylococcus aureus nasal carriage.
  • Lower airway pathogen presence in WG remains understudied.

Purpose of the Study:

  • To culture bronchoalveolar lavage fluid (BALF) from WG, idiopathic pulmonary fibrosis (IPF), and control groups.
  • To assess BALF as a growth medium for S. aureus.

Main Methods:

  • Bronchoscopy and BAL performed on 33 WG, 22 IPF, and 8 control patients.
  • Quantitative bacterial cultures and cytokine analysis (ELISA) of BALF.
  • In vitro experiments to evaluate BALF's support for S. aureus growth.

Main Results:

  • Pathogens frequently isolated from WG and IPF BALF.
  • S. aureus strongly associated with WG patients (relapse and remission).
  • Elevated BALF interleukin 1 receptor antagonist (IL1ra) in patients with pathogens.
  • WG and IPF BALF enhanced S. aureus growth compared to controls.

Conclusions:

  • WG patients exhibit higher pathogen isolation rates in BALF than IPF or controls.
  • IL1ra correlates with pathogen presence in WG and IPF.
  • WG BALF promotes S. aureus proliferation.
  • Consider S. aureus-targeted antibiotics and bronchoscopic sampling for WG.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: